期刊文献+

吲哚胺-2,3-双加氧酶/犬尿氨酸通路调控糖尿病并发抑郁症的机制研究 被引量:3

Study on the mechanism of indoleamine-2,3-dioxygenase/kynurenine pathway regulating diabetes mellitus complicated with depression
下载PDF
导出
摘要 目的:研究吲哚胺-2,3-双加氧酶(IDO)/犬尿氨酸(KYN)通路(KP)调控糖尿病并发抑郁症的机制。方法:将30只SD大鼠随机分为对照组、模型组、干预组,每组10只。模型组和干预组复制糖尿病抑郁大鼠模型。于造模成功后第8天起,干预组灌胃给予IDO抑制剂1-甲基色氨酸(1-MT)溶液14 d。采用旷场实验评估大鼠行为学改变,酶联免疫吸附试验(ELISA)法检测海马组织去甲肾上腺素(NE)、5-羟色胺(5-HT)水平及血清炎性因子水平,高效液相色谱-荧光检测法测定大鼠血清KYN水平,Western blotting法检测海马组织IDO蛋白表达。结果:与对照组比较,模型组水平运动得分和垂直竖立行为得分下降,海马组织NE、5-HT水平及血清白细胞介素(IL)-4、IL-10水平降低,血清KYN、肿瘤坏死因子-α(TNF-α)、IL-6水平及IDO蛋白表达量升高(均P<0.05)。与模型组比较,干预组水平运动得分和垂直竖立行为得分升高,海马组织中NE、5-HT水平及血清IL-4、IL-10水平升高,血清KYN、TNF-α、IL-6水平及IDO蛋白表达水平降低(均P<0.05)。结论:IDO/KP通路可能通过降低NE和5-HT水平、加重炎性反应来促进糖尿病并发抑郁症的发生发展。 Objective:To study the mechanism of indoleamine-2,3-dioxygenase(IDO)/kynurenine(KYN)pathway(KP)regulating diabetes mellitus complicated with depression.Methods:A total of 30 SD rats were randomly divided into control group,model group and intervention group,with 10 cases in each group.The diabetic depression rat model was established in the model group and the intervention group.From the 8th day after the establishment of the model,the intervention group was given IDO inhibitor 1-methyltryptophan(1-MT)solution by intragastric administration for 14 days.The behavioral changes of rats were evaluated by open field test.The levels of norepinephrine(NE),5-hydroxytryptamine(5-HT)and serum inflammatory factors in hippocampus were detected by enzyme-linked immunosorbent assay(ELISA).The level of serum KYN was determined by high performance liquid chromatography-fluorescence detection,and the expression of IDO protein in hippocampus was detected by Western blotting.Results:Compared with the control group,the scores of horizontal movement and vertical erection behavior in the model group decreased,the levels of NE and 5-HT in hippocampus and the levels of interleukin(IL)-4 and IL-10 in serum decreased,while the levels of serum KYN,tumor necrosis factor-α(TNF-α),IL-6 and IDO protein expression increased in the model group(all P<0.05).Compared with the model group,the scores of horizontal movement and vertical erection behavior in the intervention group increased,the levels of NE and 5-HT in hippocampus and the levels of IL-4 and IL-10 in serum increased,while the levels of serum KYN,TNF-α,IL-6 and IDO protein expression decreased in the intervention group(all P<0.05).Conclusion:IDO/KP pathway may promote the occurrence and development of diabetes mellitus complicated with depression by reducing the levels of NE and 5-HT and aggravating the inflammatory response.
作者 阿丽娅·吉力力 再努尔·买合木提 卢雪玲 Aliya·Jilili;Zainuer·Maihemuti;Lu Xueling(Endocrinology Department,The Seventh Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China;Department of General Practice,The Seventh Affiliated Hospital of Xinjiang Medical University,Urumqi 830054,China)
出处 《广西医科大学学报》 CAS 2022年第8期1230-1235,共6页 Journal of Guangxi Medical University
基金 新疆维吾尔自治区自然科学基金资助项目(No.2020D03006)。
关键词 吲哚胺-2 3-双加氧酶 犬尿氨酸 糖尿病并发抑郁症 炎性反应 NE 5-HT indoleamine 2,3-dioxygenase kynurenine diabetes mellitus complicated with depression inflammatory reaction NE 5-HT
  • 相关文献

参考文献1

二级参考文献3

  • 1石晓雯,周明眉,朱海燕.中药通过色氨酸-犬尿氨酸代谢途径治疗抑郁症的研究进展[J].中医药学报,2017,45(5):98-102. 被引量:5
  • 2张广芬,杨建军.NMDA受体相关抗抑郁药物的研究进展[J].中国药理学通报,2018,34(1):1-4. 被引量:16
  • 3M.Ablikim,M.N.Achasov,P.Adlarson,S.Ahmed,M.Albrecht,M.Alekseev,A.Amoroso,F.F.An,Q.An,Y.Bai,O.Bakina,R.Baldini Ferroli,Y.Ban,K.Begzsuren,J.V.Bennett,N.Berger,M.Bertani,D.Bettoni,F.Bianchi,J Biernat,J.Bloms,I.Boyko,R.A.Briere,L.Calibbi,H.Cai,X.Cai,A.Calcaterra,G.F.Cao,N.Cao,S.A.Cetin,J.Chai,J.F.Chang,W.L.Chang,J.Charles,G.Chelkov,Chen,G.Chen,H.S.Chen,J.C.Chen,M.L.Chen,S.J.Chen,Y.B.Chen,H.Y.Cheng,W.Cheng,G.Cibinetto,F.Cossio,X.F.Cui,H.L.Dai,J.P.Dai,X.C.Dai,A.Dbeyssi,D.Dedovich,Z.Y.Deng,A.Denig,Denysenko,M.Destefanis,S.Descotes-Genon,F.De Mori,Y.Ding,C.Dong,J.Dong,L.Y.Dong,M.Y.Dong,Z.L.Dou,S.X.Du,S.I.Eidelman,J.Z.Fan,J.Fang,S.S.Fang,Y.Fang,R.Farinelli,L.Fava,F.Feldbauer,G.Felici,C.Q.Feng,M.Fritsch,C.D.Fu,Y.Fu,Q.Gao,X.L.Gao,Y.Gao,Y.Gao,Y.G.Gao,Z.Gao,B.Garillon,I.Garzia,E.M.Gersabeck,A.Gilman,K.Goetzen,L.Gong,W.X.Gong,W.Gradl,M.Greco,L.M.Gu,M.H.Gu,Y.T.Gu,A.Q.Guo,F.K.Guo,L.B.Guo,R.P.Guo,Y.P.Guo,A.Guskov,S.Han,X.Q.Hao,F.A.Harris,K.L.He,F.H.Heinsius,T.Held,Y.K.Heng,Y.R.Hou,Z.L.Hou,H.M.Hu,J.F.Hu,T.Hu,Y.Hu,G.S.Huang,J.S.Huang,X.T.Huang,X.Z.Huang,Z.L.Huang,N.Huesken,T.Hussain,W.Ikegami Andersson,W.Imoehl,M.Irshad,Q.Ji,Q.P.Ji,X.B.Ji,X.L.Ji,H.L.Jiang,X.S.Jiang,X.Y.Jiang,J.B.Jiao,Z.Jiao,D.P.Jin,S.Jin,Y.Jin,T.Johansson,N.Kalantar-Nayestanaki,X.S.Kang,R.Kappert,M.Kavatsyuk,B.C.Ke,I.K.Keshk,T.Khan,A.Khoukaz,P.Kiese,R.Kiuchi,R.Kliemt,L.Koch,O.B.Kolcu,B.Kopf,M.Kuemmel,M.Kuessner,A.Kupsc,M.Kurth,M.G.Kurth,W.Kuhn,J.S.Lange,P.Larin,L.Lavezzi,H.Leithoff,T.Lenz,C.Li,Cheng Li,D.M.Li,F.Li,F.Y.Li,G.Li,H.B.Li,H.J.Li,J.C.Li,J.W.Li,Ke Li,L.K.Li,Lei Li,P.L.Li,P.R.Li,Q.Y.Li,W.D.Li,W.G.Li,X.H.Li,X.L.Li,X.N.Li,X.Q.Li,Z.B.Li,H.Liang,H.Liang,Y.F.Liang,Y.T.Liang,G.R.Liao,L.Z.Liao,J.Libby,C.X.Lin,D.X.Lin,Y.J.Lin,B.Liu,B.J.Liu,C.X.Liu,D.Liu,D.Y.Liu,F.H.Liu,Fang Liu,Feng Liu,H.B.Liu,H.M.Liu,Huanhuan Liu,Huihui Liu,J.B.Liu,J.Y.Liu,K.Y.Liu,Ke Liu,Q.Liu,S.B.Liu,T.Liu,X.Liu,X.Y.Liu,Y.B.Liu,Z.A.Liu,Zhiqing Liu,Y.F.Long,X.C.Lou,H.J.Lu,J.D.Lu,J.G.Lu,Y.Lu,Y.P.Lu,C.L.Luo,M.X.Luo,P.W.Luo,T.Luo,X.L.Luo,S.Lusso,X.R.Lyu,F.C.Ma,H.L.Ma,L.L.Ma,M.M.Ma,Q.M.Ma,X.N.Ma,X.X.Ma,X.Y.Ma,Y.M.Ma,F.E.Maas,M.Maggiora,S.Maldaner,S.Malde,Q.A.Malik,A.Mangoni,Y.J.Mao,Z.P.Mao,S.Marcello,Z.X.Meng,J.G.Messchendorp,G.Mezzadri,J.Min,T.J.Min,R.E.Mitchell,X.H.Mo,Y.J.Mo,C.Morales Morales,N.Yu.Muchnoi,H.Muramatsu,A.Mustafa,S.Nakhoul,Y.Nefedov,F.Nerling,I.B.Nikolaev,Z.Ning,S.Nisar,S.L.Niu,S.L.Olsen,Q.Ouyang,S.Pacetti,Y.Pan,M.Papenbrock,P.Patteri,M.Pelizaeus,H.P.Peng,K.Peters,A.A.Petrov,J.Pettersson,J.L.Ping,R.G.Ping,A.Pitka,R.Poling,V.Prasad,M.Qi,T.Y.Qi,S.Qian,C.F.Qiao,N.Qin,X.P.Qin,X.S.Qin,Z.H.Qin,J.F.Qiu,S.Q.Qu,K.H.Rashid,C.F.Redmer,M.Richter,M.Ripka,A.Rivetti,V.Rodin,M.Rolo,G.Rong,J.L.Rosner,Ch.Rosner,M.Rump,A.Sarantsev,M.Savrie,K.Schoenning,W.Shan,X.Y.Shan,M.Shao,C.P.Shen,P.X.Shen,X.Y.Shen,H.Y.Sheng,X.Shi,X.D Shi,J.J.Song,Q.Q.Song,X.Y.Song,S.Sosio,C.Sowa,S.Spataro,F.F.Sui,G.X.Sun,J.F.Sun,L.Sun,S.S.Sun,X.H.Sun,Y.J.Sun,Y.K Sun,Y.Z.Sun,Z.J.Sun,Z.T.Sun,Y.T Tan,C.J.Tang,G.Y.Tang,X.Tang,V.Thoren,B.Tsednee,I.Uman,B.Wang,B.L.Wang,C.W.Wang,D.Y.Wang,H.H.Wang,K.Wang,L.L.Wang,L.S.Wang,M.Wang,M.Z.Wang,Wang Meng,P.L.Wang,R.M.Wang,W.P.Wang,X.Wang,X.F.Wang,X.L.Wang,Y.Wang,Y.F.Wang,Z.Wang,Z.G.Wang,Z.Y.Wang,Zongyuan Wang,T.Weber,D.H.Wei,P.Weidenkaff,H.W.Wen,S.P.Wen,U.Wiedner,G.Wilkinson,M.Wolke,L.H.Wu,L.J.Wu,Z.Wu,L.Xia,Y.Xia,S.Y.Xiao,Y.J.Xiao,Z.J.Xiao,Y.G.Xie,Y.H.Xie,T.Y.Xing,X.A.Xiong,Q.L.Xiu,G.F.Xu,L.Xu,Q.J.Xu,W.Xu,X.P.Xu,F.Yan,L.Yan,W.B.Yan,W.C.Yan,Y.H.Yan,H.J.Yang,H.X.Yang,L.Yang,R.X.Yang,S.L.Yang,Y.H.Yang,Y.X.Yang,Yifan Yang,Z.Q.Yang,M.Ye,M.H.Ye,J.H.Yin,Z.Y.You,B.X.Yu,C.X.Yu,J.S.Yu,C.Z.Yuan,X.Q.Yuan,Y.Yuan,A.Yuncu,A.A.Zafar,Y.Zeng,B.X.Zhang,B.Y.Zhang,C.C.Zhang,D.H.Zhang,H.H.Zhang,H.Y.Zhang,J.Zhang,J.L.Zhang,J.Q.Zhang,J.W.Zhang,J.Y.Zhang,J.Z.Zhang,K.Zhang,L.Zhang,S.F.Zhang,T.J.Zhang,X.Y.Zhang,Y.Zhang,Y.H.Zhang,Y.T.Zhang,Yang Zhang,Yao Zhang,Yi Zhang,Yu Zhang,Z.H.Zhang,Z.P.Zhang,Z.Q.Zhang,Z.Y.Zhang,G.Zhao,J.W.Zhao,J.Y.Zhao,J.Z.Zhao,Lei Zhao,Ling Zhao,M.G.Zhao,Q.Zhao,S.J.Zhao,T.C.Zhao,Y.B.Zhao,Z.G.Zhao,A.Zhemchugov,B.Zheng,J.P.Zheng,Y.Zheng,Y.H.Zheng,B.Zhong,L.Zhou,L.P.Zhou,Q.Zhou,X.Zhou,X.K.Zhou,Xingyu Zhou,Xiaoyu Zhou,Xu Zhou,A.N.Zhu,J.Zhu,J.Zhu,K.Zhu,K.J.Zhu,S.H.Zhu,W.J.Zhu,X.L.Zhu,Y.C.Zhu,Y.S.Zhu,Z.A.Zhu,J.Zhuang,B.S.Zou,J.H.Zou,无.Future Physics Programme of BESⅢ[J].Chinese Physics C,2020,44(4). 被引量:544

共引文献10

同被引文献70

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部